You are here

Resource Center

FDA-2014-D-0900 Benefit-Risk Factors To Consider When Determining Substantial Equivalence in Premarket Notifications [510(k)] With Different Technological Characteristics

Comments

application/pdf - 872.3 kB
Date:
10/13/2014
Issues: